Topological models for the prediction of antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines

Medicinal Chemistry Research

Volumn 21, Issue 7, 2012, Pages 1363-1375

  Judge, Vikramjeet ^a   Narasimhan, Balasubramanian ^b   Ahuja, Munish ^a  

^a Guru Jambheswar University of Science and Technology   (India)

^b MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

4 (5 substituted 1,3,4 oxadiazol 2 yl)pyridines; Antimycobacterial; QSAR; Topological index

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; ANTIMYCOBACTERIAL AGENT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

EID: 84861839099     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9645-x     Document Type: Article

References (38)

1. Amigo JM, Galvez J, Villar VM (2009) A review on molecular topology: applying graph theory to drug discovery and design. Naturwissenschaften 96:749-761
2. Balaban AT (1982) Highly discriminating distance based topological indices. Chem Phys Lett 89:399-404
3. Benetton SA, Kedor-Hackmann ERM, Santoro MIRM, Borges VM (1998) Visible spectrophotometric and first derivative UV spectrophotometric determination of rifampicin and isoniazid in pharmaceutical preparations. Talanta 47:639-643
4. Chiu TL, So SS (2004) Development of neural network QSPR models for Hansch substituent constants. 1. Method and validations. J Chem Inf Comput Sci 44(1):147-153
5. Cruz-Monteagudo M, Gonzalez-Diaz H, Aguero-Chapin G, Santana L, Borges F, Dominguez ER, Podda G, Uriarte E (2007) Computational chemistry development of a unified free energy Markov model for the distribution of 1300 chemicals to 38 different environmental or biological systems. J Comput Chem 28(11):1909-1923
6. Dewangan D, Pandey A, Sivakumar T, Rajavel R, Dubey RD (2010) Synthesis of some novel 2, 5-disubstituted 1, 3, 4-oxadiazole and its analgesic, anti-inflammatory, anti-bacterial and anti-tubercular activity. Int J Chem Tech Res 2(3):1397-1412
7. Galvez J, Garcia-Domenech R, Bernal J, Garcia-March F (1991) Drug design based upon molecular topology: application to nonnarcotic analgesics. Anales de la Real Academia de Farmacia 57:533-546
8. Golbraikh A, Tropsha A (2002) Beware of q2!. J Mol Graphics Model 20:269-276
9. Gonzalez-Diaz H, Prado-Prado FJ (2008) Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: Multispecies activity models for antifungals. J Comput Chem 29(4):656-667
10. Gonzalez-Diaz H, Vilar S, Santana L, Uriarte E (2007) Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr Top Med Chem 7(10):1015-1029
11. Gonzalez-Diaz H, Gonzalez-Diaz Y, Santana L, Ubeira FM, Uriarte E (2008) Networks and connectivity indices. Proteomics 8(4):750-778
12. Hansch C, Fujita T (1964) p-r-p Analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 86:1616-1626
13. Hansch C, Leo A, Unger SH, Kim KH, Nikaitani D, Lien EJ (1973) Aromatic substituent constants for structure-activity correlations. J Med Chem 16:1207-1216
14. Jalali-Heravi M, Kyani A (2004) Use of computer-assisted methods for the modeling of the retention time of a variety of volatile organic compounds: A PCA-MLR-ANN approach. J Chem Inf Comput Sci 44:1328-1335
15. Judge V, Narang R, Sharma D, Narasimhan B, Kumar P (2010) Hansch analysis for the prediction of antimycobacterial activity of ofloxacin derivatives. Med Chem Res. doi:10.1007/s00044-010-9400-8
16. Karelson M, Maran U, Wang Y, Katritzky AR (1999) QSPR and QSAR models derived with CODESSA multipurpose statistical analysis software. AAAI technical report SS-99-01. Compilation copyright, 1999 (www.aaai.org)
17. Kier LB, Hall LH (1976) Molecular connectivity in chemistry and drug research. Academic Press, New York
18. Kier LB, Hall LH (1999) In: Devillers J, Balaban AT (eds) Topological indices and related descriptors in QSAR and QSPR. Gordon and Breach Sci. Pub., Amsterdam, pp 455-489
19. Lather V, Madan AK (2005) Topological models for the prediction of anti-HIV activity of dihydro (alkylthio) (napthylmethyl) oxopyrimidines. Bioorg Med Chem 13:1599-1604
20. Mandloi D, Joshi S, Khadikar PV, Khosla N (2005) QSAR study on the antibacterial activity of some sulfa drugs: building blockers of Mannich bases. Bioorg Med Chem Lett 15:405-411
21. Narasimhan B, Kumari M, Jain N, Dhake AS, Sundaravelan C (2006a) Correlation of antibacterial activity of some N-[5-(2-furanyl)-2-methyl-4-oxo- 4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-substituted-5-(2-furanyl)-2- methyl-3H-thieno[2,3-d] pyrimidin-4-ones with topological indices using Hansch analysis. Biorg Med Chem Lett 16:4951-4958
22. Narasimhan B, Mourya VK, Dhake AS (2006b) Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives. Bioorg Med Chem Lett 16:3023-3029
23. Narasimhan B, Judge V, Narang R, Ohlan S, Ohlan R (2007) Quantitative structure activity relationship studies for prediction of antimicrobial activity of synthesized 2, 4-hexadienoic acid derivatives. Bioorg Med Chem Lett 17:5836-5845
24. Navarrete-Vazquez G, Molina-Salinas GM, Duarte-Fajardo ZV, Vargas-Villarreal J, Estrada-Soto S, Gonzalez-Salazar F, Hernandez- Nunez E, Said-Fernandez S (2007) Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines. Bioorg Med Chem 15:5502-5508
25. Nunn CM, Djordjevic S, Hillas PJ, Nishida CR, Ortiz de Montellano PR (2002) The crystal structure of Mycobacterium tuberculosis alkylhydroperoxidase AhpD, a potential target for antitubercular drug design. J Biol Chem 277(22):20034-20040
26. Pinheiro AAC, Borges RS, Santos SL, Alves CN (2004) A QSAR study of 8.O.40-neolignans with antifungal activity. J Struct Mol (Theochem) 672:215-219
27. Prado-Prado FJ, Gonzalez-Diaz H, Vega OMDL, Ubeira FM, Chou KC (2008) First multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg Med Chem 16(11):5871-5880
28. Randic M (1975) On the characterization of molecular branching. J Am Chem Soc 97:6609-6615
29. Randic M (1993) Comparative regression analysis-regressions based on single descriptor. Croat Chem Acta 66:289-312
30. Shahar Yar M, Siddiqui AA, Ali MA (2007) Synthesis and antimycobacterial activity of novel heterocycles. J Serb Chem Soc 72(1):5-11
31. Sharma S, Sharma BK, Prabhakar YS (2009) Juglone derivatives as antitubercular agents: a rationale for the activity profile. Eur J Med Chem 44(7):2847-2853
32. Sidhaye RV, Dhanawade AE, Manasa K, Aishwarya G (2011) Synthesis, antimicrobial and antimycobacterial activity of nicotinic acid hydrazide derivatives. Curr Pharma Res CPR 1(2):135-139
33. Singh S, Mandal PK, Misra AK, Singh N, Singh S, Sinha S, Chaturvedi V, Saxena AK (2010) Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR). Bioorg Med Chem Lett 20(8):2597-2600
34. Skvortsova MI, Palyulin VA, Zefirov NS (2009) Design of topological indices: computer oriented approach. SAR QSAR Environ Res 20:357-377
35. SPSS Inc (1999) SPSS for windows, version 10.05. SPSS Inc., Bangalore
36. TSAR 3D version 3.3 (2000) Oxford Molecular Limited
37. Wiener H (1947) Structural determination of paraffin boiling points. J Am Chem Soc 69:17-20
38. Xu L, Yang JA, Wu YP (2002) Effective descriptions of molecular structures and the quantitative structure-activity relationship studies. J Chem Inf Comput Sci 42(3):602-606